Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

0QDU

Abliva Ab (0QDU)

Abliva Ab
일자:
정렬 기준:
 검색 관련기사 보기:LSE:0QDU
일자시간출처헤드라인심볼기업
2020/02/1917:03PR Newswire (US)NeuroVive Pharmaceutical AB Year End Report January - December 2019LSE:0QDUAbliva Ab
2020/02/1917:01PR Newswire (US)NeuroVive Pharmaceutical AB Year End Report January - December 2019LSE:0QDUAbliva Ab
2019/12/2023:44PR Newswire (US)NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b StudyLSE:0QDUAbliva Ab
2019/12/2023:40PR Newswire (US)NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b StudyLSE:0QDUAbliva Ab
2019/12/1619:21PR Newswire (US)NeuroVive Announces Settlement in Dispute With CicloMulsion AGLSE:0QDUAbliva Ab
2019/12/1619:19PR Newswire (US)NeuroVive Announces Settlement in Dispute With CicloMulsion AGLSE:0QDUAbliva Ab
2019/11/2017:04PR Newswire (US)NeuroVive Pharmaceutical AB Interim Report January - September 2019LSE:0QDUAbliva Ab
2019/11/2016:58PR Newswire (US)NeuroVive Pharmaceutical AB Interim Report January - September 2019LSE:0QDUAbliva Ab
2019/08/2115:55PR Newswire (US)NeuroVive Pharmaceutical AB Interim Report January - June 2019LSE:0QDUAbliva Ab
2019/08/2115:52PR Newswire (US)NeuroVive Pharmaceutical AB Interim Report January - June 2019LSE:0QDUAbliva Ab
2019/08/2020:23PR Newswire (US)Save the Date: NeuroVive to host Capital Markets Day in Stockholm on 9 October, 2019LSE:0QDUAbliva Ab
2019/07/2720:38PR Newswire (US)NeuroVive's NeuroSTAT Project Receives FDA Fast Track DesignationLSE:0QDUAbliva Ab
2019/07/2720:35PR Newswire (US)NeuroVive's NeuroSTAT Project Receives FDA Fast Track DesignationLSE:0QDUAbliva Ab
2019/07/0421:46PR Newswire (US)NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical StudyLSE:0QDUAbliva Ab
2019/07/0421:45PR Newswire (US)NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical StudyLSE:0QDUAbliva Ab
2019/05/2115:45PR Newswire (US)NeuroVive Pharmaceutical AB Interim Report January - March 2019LSE:0QDUAbliva Ab
2019/05/1015:48PR Newswire (US)NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDALSE:0QDUAbliva Ab
2019/05/1015:46PR Newswire (US)NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDALSE:0QDUAbliva Ab
2019/03/2518:48PR Newswire (US)NeuroVive Pharmaceutical AB Publishes 2018 Annual ReportLSE:0QDUAbliva Ab
2019/03/2518:43PR Newswire (US)NeuroVive Pharmaceutical AB Publishes 2018 Annual ReportLSE:0QDUAbliva Ab
2019/03/0717:07PR Newswire (US)NeuroVive Receives SEK 28.2 Million in a Directed New Share IssueLSE:0QDUAbliva Ab
2019/02/2116:52PR Newswire (US)NeuroVive Enters Commercial Partnership With Oroboros Instruments on Mitochondrial Medicine Research CompoundsLSE:0QDUAbliva Ab
2018/11/1520:25PR Newswire (US)NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial DisordersLSE:0QDUAbliva Ab
2018/11/1520:21PR Newswire (US)NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial DisordersLSE:0QDUAbliva Ab
2018/10/3117:07PR Newswire (US)NeuroVive Today Announces That the Subscription Period for Warrants of Series 2018:1 Will Begin on Thursday, November 1LSE:0QDUAbliva Ab
2018/10/0415:50PR Newswire (US)NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBILSE:0QDUAbliva Ab
2018/10/0415:45PR Newswire (US)NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBILSE:0QDUAbliva Ab
2017/12/1119:41PR Newswire (US)NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333LSE:0QDUAbliva Ab
2017/12/1119:38PR Newswire (US)NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333LSE:0QDUAbliva Ab
 검색 관련기사 보기:LSE:0QDU